Quantification of Head Tremors in Medical Conditions: A Comparison of Analyses Using a 2D Video Camera and a 3D Wireless Inertial Motion Unit.

2D video motion analysis Fourier transform head tremor amplitude head tremor frequency miniature wireless inertial magnetic motion unit wavelet transform

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
19 Mar 2022
Historique:
received: 02 02 2022
revised: 10 03 2022
accepted: 17 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 31 3 2022
Statut: epublish

Résumé

This study compares two methods to quantify the amplitude and frequency of head movements in patients with head tremor: one based on video-based motion analysis, and the other using a miniature wireless inertial magnetic motion unit (IMMU). Concomitant with the clinical assessment of head tremor severity, head linear displacements in the frontal plane and head angular displacements in three dimensions were obtained simultaneously in forty-nine patients using one video camera and an IMMU in three experimental conditions while sitting (at rest, counting backward, and with arms extended). Head tremor amplitude was quantified along/around each axis, and head tremor frequency was analyzed in the frequency and time-frequency domains. Correlation analysis investigated the association between the clinical severity of head tremor and head linear and angular displacements. Our results showed better sensitivity of the IMMU compared to a 2D video camera to detect changes of tremor amplitude according to examination conditions, and better agreement with clinical measures. The frequency of head tremor calculated from video data in the frequency domain was higher than that obtained using time-frequency analysis and those calculated from the IMMU data. This study provides strong experimental evidence in favor of using an IMMU to quantify the amplitude and time-frequency oscillatory features of head tremor, especially in medical conditions.

Identifiants

pubmed: 35336555
pii: s22062385
doi: 10.3390/s22062385
pmc: PMC8955151
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Programme Hospitalier de Recherche Clinique from the French Health Ministry. (2014)
ID : PHRC-14-0058

Références

Clin Neuropharmacol. 1989 Aug;12(4):293-7
pubmed: 2804993
Parkinsonism Relat Disord. 2021 Jun;87:124-129
pubmed: 34030068
J Neurosci Methods. 2005 Jun 30;145(1-2):151-8
pubmed: 15922033
Sensors (Basel). 2019 Sep 30;19(19):
pubmed: 31574913
Mov Disord Clin Pract. 2016 Jul 08;4(2):205-211
pubmed: 30363428
Mov Disord. 2016 Sep;31(9):1327-36
pubmed: 27273470
Mov Disord. 2018 Jan;33(1):75-87
pubmed: 29193359
Mov Disord. 2013 Nov;28(13):1793-800
pubmed: 24038576
Brain. 2006 Oct;129(Pt 10):2660-6
pubmed: 16891320
Stereotact Funct Neurosurg. 2015 Feb 18;93(2):94-101
pubmed: 25720954
Lancet Neurol. 2011 Feb;10(2):148-61
pubmed: 21256454
Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:906-9
pubmed: 25570106
Neuroimage. 2011 Apr 15;55(4):1504-18
pubmed: 21256224
Mov Disord Clin Pract. 2017 Nov 23;5(1):60-65
pubmed: 30363460
Mov Disord. 2006 Aug;21(8):1245-8
pubmed: 16673401
Mov Disord. 1997 Sep;12(5):722-6
pubmed: 9380055
J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):187-9
pubmed: 17872981
J Neurosci Methods. 1997 Jun 6;74(1):77-87
pubmed: 9210577
Tremor Other Hyperkinet Mov (N Y). 2012;2:
pubmed: 23439931
Mov Disord. 2009 Apr 15;24(5):723-30
pubmed: 19133661
Tremor Other Hyperkinet Mov (N Y). 2016 May 17;6:375
pubmed: 27257514
Neurology. 1995 Apr;45(4):822-4
pubmed: 7723978
J Neurol Neurosurg Psychiatry. 1993 Aug;56(8):868-73
pubmed: 8350102

Auteurs

David Amarantini (D)

Toulouse NeuroImaging Center (ToNIC), Inserm, UPS, Université de Toulouse, 31024 Toulouse, France.

Isabelle Rieu (I)

Department of Neurology, CNRS, CHU Clermont-Ferrand, Institut Pascal, Université Clermont-Auvergne, 63001 Clermont-Ferrand, France.

Giovanni Castelnovo (G)

Service de Neurologie, Centre Hospitalier Universitaire Caremeau, 30029 Nîmes, France.

Frédérique Fluchère (F)

Department of Neurology and Movement Disorders, Timone Hospital, Aix-Marseille Université, 13005 Marseille, France.

Chloé Laurencin (C)

Université de Lyon, Université Claude Bernard Lyon 1, Lyon Neuroscience Research Center, INSERM, U 1028, CNRS, UMR 5292, Neuroplasticity and Neuropathology of Olfactory Perception team, 69000 Lyon, France.
Service de Neurologie C, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon (HCL), 69000 Lyon, France.

Bertrand Degos (B)

Service de Neurologie, APHP, Hôpital Avicenne, Université Sorbonne Paris Nord, 93000 Bobigny, France.
Dynamics and Pathophysiology of Neuronal Networks Team, Center for Interdisciplinary Research in Biology, Collège de France, CNRS UMR7241/Inserm U1050, Université Paris Sciences & Lettres (PSL), 75005 Paris, France.

Aurélia Poujois (A)

Neurology Department, Rothschild Foundation Hospital, 75019 Paris, France.

Alexandre Kreisler (A)

Service de Neurologie A, Movement Disorders Unit, CHU Lille, 59037 Lille, France.

Sophie Sangla (S)

Unité Parkinson, Hôpital Fondation Rothschild, 75019 Paris, France.

Mélissa Tir (M)

Department of Neurology and the Department of Neurosurgery, Expert Centre for Parkinson's Disease, Amiens University Hospital, 80054 Amiens, France.
EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP), University of Picardy Jules Verne (UPJV), 80054 Amiens, France.

Isabelle Benatru (I)

Department of Neurology, University Hospital of Poitiers, 86000 Poitiers, France.
INSERM, CHU de Poitiers, University of Poitiers, Centre d'Investigation Clinique CIC1402, 86000 Poitiers, France.

Geneviève Blanchet-Fourcade (G)

Service de Neurologie, Narbonne Hospital Centre, 11100 Narbonne, France.

Dominique Guehl (D)

Centre Hospitalier Universitaire de Bordeaux, Institut des Maladies Neurodégénératives, CNRS, University of Bordeaux, 33000 Bordeaux, France.

Dominique Gayraud (D)

Service de Neurologie, Centre Hospitalier Intercommunal Aix-Pertuis, Site d'Aix-en-Provence, Avenue des Tamaris, 13616 Aix-en-Provence, France.

Laurent Tatu (L)

Department of Neuromuscular Diseases and Department of Anatomy, CHRU Besançon, University of Franche-Comté, 25030 Besançon, France.

Christine Tranchant (C)

Department of Neurology, CHU Hautepierre, 67000 Strasbourg, France.

Franck Durif (F)

Department of Neurology, CNRS, CHU Clermont-Ferrand, Institut Pascal, Université Clermont-Auvergne, 63001 Clermont-Ferrand, France.

Marion Simonetta-Moreau (M)

Toulouse NeuroImaging Center (ToNIC), Inserm, UPS, Université de Toulouse, 31024 Toulouse, France.
Department of Neurology, University Hospital of Toulouse, 31300 Toulouse, France.
Clinical Investigation Center (CIC 1436), Toulouse University Hospital, INSERM, 31059 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH